Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Mizuho Upgrades Atara Biotherapeutics to Outperform, Lowers Price Target to $18

Author: Benzinga Newsdesk | August 16, 2024 01:42pm

Mizuho analyst Salim Syed upgrades Atara Biotherapeutics (NASDAQ:ATRA) from Neutral to Outperform and lowers the price target from $25 to $18.

Posted In: ATRA